Literature DB >> 22817524

Safety of the open-irrigated ablation catheter for radiofrequency ablation: safety analysis from six clinical studies.

Albert L Waldo1, David J Wilber, Francis E Marchlinski, William G Stevenson, Brenda Aker, Lee Ming Boo, Warren M Jackman.   

Abstract

BACKGROUND: The open-irrigated catheter is used most frequently for atrial and ventricular radiofrequency ablation (RFA), and is often considered as the standard by which new ablation systems are compared. But few data have been published concerning its safety. This report provides a comprehensive safety analysis of the use of an open-irrigated catheter for RFA of atrial flutter, ventricular tachycardia, and atrial fibrillation in 1,275 patients in six rigorously monitored, prospective, multicenter studies.
METHODS: This analysis is of data from six studies conducted as part of both Food and Drug Administration-mandated investigational device exemption studies and postapproval studies. The six studies span a period of more than 10 years. All serious RFA complications and vascular access complications that occurred within seven days postprocedure were included.
RESULTS: The number of patients who experienced any acute serious RFA complication in these studies combined was 4.9% (63/1,275). The two earliest studies were conducted when the open-irrigated catheter was first introduced, and accounted for 55.6% of the complications. In the first atrial flutter ablation study, RFA complications decreased by 60% (15.4%-6.2%) after a proctoring program was initiated during the study. For all studies, vascular access complications ranged between from 0.5%-4.7%, and no stroke or transient ischemic attack was reported within 7 days postprocedure. No significant pulmonary vein stenosis was reported from the atrial fibrillation studies.
CONCLUSION: A proctoring program, careful fluid management, and absence of char and coagulum contributed to the safe use of the open-irrigated RFA catheter. ©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22817524     DOI: 10.1111/j.1540-8159.2012.03480.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

1.  Continuous ablation improves lesion maturation compared with intermittent ablation strategies.

Authors:  Albert J Rogers; Ryan T Borne; Grant Ho; William H Sauer; Paul J Wang; Sanjiv M Narayan; Lijun Zheng; Duy T Nguyen
Journal:  J Cardiovasc Electrophysiol       Date:  2020-04-27

2.  Medical device postapproval safety monitoring: where does the United States stand?

Authors:  Prashant V Rajan; Daniel B Kramer; Aaron S Kesselheim
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-01-06

3.  Catheter-tissue contact force values do not impact mid-term clinical outcome following pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Authors:  Giuseppe Stabile; Francesco Solimene; Leonardo Calò; Matteo Anselmino; Antonello Castro; Claudio Pratola; Paolo Golia; Nicola Bottoni; Giuseppe Grandinetti; Antonio De Simone; Vincenzo Schillaci; Emanuele Bertaglia; Roberto De Ponti
Journal:  J Interv Card Electrophysiol       Date:  2014-11-07       Impact factor: 1.900

Review 4.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

5.  Clinical Impact of Saline Volume Infused Through Irrigated-Tip Ablation Catheter in Low Acuity Paroxysmal Atrial Fibrillation Ablation Patients.

Authors:  Nagesh Chopra; Anish K Amin; Anand Gupta; Eugene Y Fu; Allan J Nichols; Steven D Nelson; James M Kleman; James M Kleman; Gregory A Kidwell; Sreedhar R Billakanty
Journal:  J Atr Fibrillation       Date:  2018-12-31

6.  Acute safety of an open-irrigated ablation catheter with 56-hole porous tip for radiofrequency ablation of paroxysmal atrial fibrillation: analysis from 2 observational registry studies.

Authors:  Saumil R Oza; Tina D Hunter; Angelo B Biviano; Gopi Dandamudi; Bengt Herweg; Anshul M Patel; Scott J Pollak; Huijian Wang; Robert S Fishel
Journal:  J Cardiovasc Electrophysiol       Date:  2014-04-09

7.  A prospective multi-site registry of real-world experience of catheter ablation for treatment of symptomatic paroxysmal and persistent atrial fibrillation (Real-AF): design and objectives.

Authors:  Allyson L Varley; Omar Kreidieh; Brigham E Godfrey; Carolyn Whitmire; Susan Thorington; Benjamin D'Souza; Steven Kang; Shrinivas Hebsur; Bipin K Ravindran; Edwin Zishiri; Brett Gidney; Matthew B Sellers; David Singh; Tariq Salam; Mark Metzl; Alex Ro; Jose Nazari; Westby G Fisher; Alexandru Costea; Anthony Magnano; Saumil Oza; Gustavo Morales; Anil Rajendra; Joshua Silverstein; Paul C Zei; Jose Osorio
Journal:  J Interv Card Electrophysiol       Date:  2021-07-02       Impact factor: 1.900

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.